Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric McDade

Showing results (41-50 of 194) with videos related to

Pageof 20
Sort By:
Neuroimage. Clinical|December 8, 2015
Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjectsJames M Mountz, Charles M Laymon, Ann D Cohen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentTammie L S Benzinger, Arnaud Charil, Brian A Gordon, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 10, 2015
Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older AdultsBeth E Snitz, Lisa A Weissfeld, Ann D Cohen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 5, 2020
The pathway to secondary prevention of Alzheimer's diseaseEric McDade, Martin M Bednar, H Robert Brashear, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentSharon Cohen, Simon Ducharme, Jared R Brosch, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 27, 2020
A randomized controlled trial of amyloid positron emission tomography results disclosure in mild cognitive impairmentJennifer H Lingler, Susan M Sereika, Meryl A Butters, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 20, 2024
Statistical considerations when estimating time-saving treatment effects in Alzheimer's disease clinical trialsGuoqiao Wang, Gary Cutter, Neil P Oxtoby, et al.
The American Journal of Psychiatry|July 31, 2013
The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's diseaseOscar L Lopez, James T Becker, Yue-Fang Chang, et al.
Neurology|July 18, 2014
Cerebral perfusion alterations and cerebral amyloid in autosomal dominant Alzheimer diseaseEric McDade, Albert Kim, Jeffrey James, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 28, 2025
Evaluating pathogenicity of variants of unknown significance in APP, PSEN1, and PSEN2Jacob A Marsh, Guangming Huang, Kevin Bowling, et al.
Pageof 20

Showing results (41-50 of 194) with videos related to

Sort By:
Pageof 20
Neuroimage. Clinical|December 8, 2015
Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjectsJames M Mountz, Charles M Laymon, Ann D Cohen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentTammie L S Benzinger, Arnaud Charil, Brian A Gordon, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 10, 2015
Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older AdultsBeth E Snitz, Lisa A Weissfeld, Ann D Cohen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 5, 2020
The pathway to secondary prevention of Alzheimer's diseaseEric McDade, Martin M Bednar, H Robert Brashear, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentSharon Cohen, Simon Ducharme, Jared R Brosch, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 27, 2020
A randomized controlled trial of amyloid positron emission tomography results disclosure in mild cognitive impairmentJennifer H Lingler, Susan M Sereika, Meryl A Butters, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 20, 2024
Statistical considerations when estimating time-saving treatment effects in Alzheimer's disease clinical trialsGuoqiao Wang, Gary Cutter, Neil P Oxtoby, et al.
The American Journal of Psychiatry|July 31, 2013
The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's diseaseOscar L Lopez, James T Becker, Yue-Fang Chang, et al.
Neurology|July 18, 2014
Cerebral perfusion alterations and cerebral amyloid in autosomal dominant Alzheimer diseaseEric McDade, Albert Kim, Jeffrey James, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 28, 2025
Evaluating pathogenicity of variants of unknown significance in APP, PSEN1, and PSEN2Jacob A Marsh, Guangming Huang, Kevin Bowling, et al.
Pageof 20